Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The XIII Eurasian Hematology-Oncology Congress (EHOC) was held on 5-8 October 2022 in Istanbul, Turkey, and saw hemonc experts gather to discuss the latest updates in adult and pediatric hematology and nursing.
Watch our excellent interview with Manali Kamdar (@mana1981) of @CUCancerCenter to hear the findings of subgroup analyses of the TRANSCEND-NHL-001 trial #MantleCellLymphoma cohort!
Tagraxofusp, a first‐in‐class #CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature - Jen - 2024 - Cancer | @jenweiying @mkonople @doctorpemm #endcancer #BPDCN @JournalCancer
Check out this week's podcast, where you'll learn about the role of BTK inhibitors in the treatment of mantle cell lymphoma, directly from leading experts! 🎧🩸
The XIII Eurasian Hematology-Oncology Congress (EHOC) was held on 5-8 October 2022 in Istanbul, Turkey, and saw hemonc experts gather to discuss the latest updates in adult and pediatric hematology and nursing.
Watch our excellent interview with Manali Kamdar (@mana1981) of @CUCancerCenter to hear the findings of subgroup analyses of the TRANSCEND-NHL-001 trial #MantleCellLymphoma cohort!
Tagraxofusp, a first‐in‐class #CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature - Jen - 2024 - Cancer | @jenweiying @mkonople @doctorpemm #endcancer #BPDCN @JournalCancer
Check out this week's podcast, where you'll learn about the role of BTK inhibitors in the treatment of mantle cell lymphoma, directly from leading experts! 🎧🩸
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.